Lisa Murphy/LinkedIn
Oct 26, 2025, 15:39
Lisa Murphy on Life After Stroke Sessions at WSC 2025
Lisa Murphy, Chief Executive Officer at Stroke Foundation, shared on LinkedIn:
”The World Stroke Organization WSC 2025 has come to an end…and what a great few days of learning and collaboration and new friends!
Such diversity in the life after stroke and lived experience engagement program
Life After Stroke Sessions:
- Creative approaches – with Louis Gustin (comics), Christopher Bailey (Art), Hardeep S. (Photos) and Shamala Thilarajah (creative therapy)
- Inequities – with Joesph Rukelibuga (Rwanda Stoke Action), Bruce Ovbiagele (underrepresented communities), Caitlin Longman (communication difficulties), Dr Emmie Malewezi (low income settings)
- Involvement in research- with Maria Luisa Vives de Delás (setting up Hola Que Tal Afasia), Lisa Kidd (lived experience and research), Michelle L.A. Nelson (journey as an academic) and me (meaningful engagement).
- The SSO Stroke Exchange Workshops starting the ideation of our new organisation framework
- Unpacking research partnerships workshop with Brina Ludwig Prout and Marina Charalambous
A huge thanks goes to Sarah Belson for pulling this all together and my co-chair Michelle L.A. Nelson.
So good spending time with you both!”

More from WSC 2025 featured in Hemostasis Today.
Brina Ludwig Prout
Bruce Ovbiagele
Caitlin Longman
Christopher Bailey
Emmie Malewezi
Hardeep S.
Health
Hematology
Hemostasis
Hemostasis Today
Hola Que Tal Afasia
Joesph Rukelibuga
Life After Stroke
Lisa Kidd
Lisa Murphy
LMIC
Louis Gustin
Maria Luisa Vives de Delás
Marina Charalambous
Medicine
Michelle L.A. Nelson
Rwanda Stoke Action
Sarah Belson
Shamala Thilarajah
thrombosis
World Stroke Organization
WSC 2025
WSO
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction